Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-11.87%)
Close on Nov 13, 2026Market cap $3.86MP/E –Yield –
Traws Pharma operating margin
Operating margin is operating income as a percentage of revenue.
Traws Pharma's operating margin for the twelve months ending Dec 31, 2025 was -640.7%. For fiscal 2025 it was -640.7%, against -62997.3% the year before. The highest annual figure on record is -48.2% in fiscal 2012.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -640.7% | +62356.7 |
| FY2024 | Dec 31, 2024 | -62997.3% | −54015.9 |
| FY2023 | Dec 31, 2023 | -8981.4% | −296.9 |
| FY2022 | Dec 31, 2022 | -8684.5% | −1385.4 |
| FY2021 | Dec 31, 2021 | -7299.1% | +3520.4 |
| FY2020 | Dec 31, 2020 | -10819.5% | −9825.5 |
| FY2019 | Dec 31, 2019 | -994.0% | +901.9 |
| FY2018 | Dec 31, 2018 | -1895.9% | +1374.3 |
| FY2017 | Dec 31, 2017 | -3270.3% | −2842.9 |
| FY2016 | Dec 31, 2016 | -427.4% | −218.1 |
| FY2015 | Dec 31, 2015 | -209.3% | +7758.7 |
| FY2014 | Dec 31, 2014 | -7968.0% | −6658.9 |
| FY2013 | Dec 31, 2013 | -1309.1% | −1260.9 |
| FY2012 | Dec 31, 2012 | -48.2% | +1806.0 |
| FY2011 | Dec 31, 2011 | -1854.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -45.7% | +216354.3 |
| Q1 FY2025 | Mar 31, 2025 | -9128.1% | +179.1 |
| Q4 FY2024 | Dec 31, 2024 | -9425.0% | −1457.1 |
| Q3 FY2024 | Sep 30, 2024 | -14975.4% | −6047.4 |
| Q2 FY2024 | Jun 30, 2024 | -216400.0% | −208312.3 |
| Q1 FY2024 | Mar 31, 2024 | -9307.1% | +1651.8 |
| Q4 FY2023 | Dec 31, 2023 | -7967.9% | +2271.4 |
| Q3 FY2023 | Sep 30, 2023 | -8928.1% | +968.4 |
| Q2 FY2023 | Jun 30, 2023 | -8087.7% | −859.6 |
| Q1 FY2023 | Mar 31, 2023 | -10958.9% | −3580.4 |
| Q4 FY2022 | Dec 31, 2022 | -10239.3% | −3519.6 |
| Q3 FY2022 | Sep 30, 2022 | -9896.5% | −2896.5 |
| Q2 FY2022 | Jun 30, 2022 | -7228.1% | +921.1 |
| Q1 FY2022 | Mar 31, 2022 | -7378.6% | −60.7 |
| Q4 FY2021 | Dec 31, 2021 | -6719.6% | +4254.0 |
| Q3 FY2021 | Sep 30, 2021 | -7000.0% | +2506.1 |
| Q2 FY2021 | Jun 30, 2021 | -8149.1% | +4956.2 |
| Q1 FY2021 | Mar 31, 2021 | -7317.9% | +2537.9 |
| Q4 FY2020 | Dec 31, 2020 | -10973.7% | +8119.6 |
| Q3 FY2020 | Sep 30, 2020 | -9506.1% | −1414.0 |
| Q2 FY2020 | Jun 30, 2020 | -13105.4% | −12925.7 |
| Q1 FY2020 | Mar 31, 2020 | -9855.8% | +792.8 |
| Q4 FY2019 | Dec 31, 2019 | -19093.3% | −8674.7 |
| Q3 FY2019 | Sep 30, 2019 | -8092.1% | −3430.4 |
| Q2 FY2019 | Jun 30, 2019 | -179.7% | +983.0 |
| Q1 FY2019 | Mar 31, 2019 | -10648.5% | −9602.1 |
| Q4 FY2018 | Dec 31, 2018 | -10418.6% | −6141.0 |
| Q3 FY2018 | Sep 30, 2018 | -4661.7% | +1482.9 |
| Q2 FY2018 | Jun 30, 2018 | -1162.7% | +710.5 |
| Q1 FY2018 | Mar 31, 2018 | -1046.5% | +2187.8 |
| Q4 FY2017 | Dec 31, 2017 | -4277.6% | −537.7 |
| Q3 FY2017 | Sep 30, 2017 | -6144.5% | −5883.2 |
| Q2 FY2017 | Jun 30, 2017 | -1873.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -3234.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -3739.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -261.4% | – |
See a number that looks wrong?